ICARES Medicus (ROCO:6612) Total Long-Term Assets: NT$1,438 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6612 ICARES Medicus Inc ROCO:6612
85 GF Score
Price NT$70.80
GF Value NT$152.19
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is ICARES Medicus Total Long-Term Assets?

ICARES Medicus ROCO:6612 -0.28% 85 Total Long-Term Assets is NT$1,438 Mil as of Jun. 2026. GuruFocus rates ROCO:6612 with a GF Score™ of 85/100 and a GF Value™ of NT$152.19 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. ICARES Medicus's Total Long-Term Assets for the quarter that ended in Jun. 2026 was NT$1,438 Mil.

ICARES Medicus Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for ICARES Medicus's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ICARES Medicus Total Long-Term Assets Chart

ICARES Medicus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 408.99 382.46 615.62 1,594.87 1,478.66

ICARES Medicus Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,450.15 1,465.10 1,478.66 1,482.35 1,438.33
ROCO:6612
85GF Score
ICARES Medicus Inc ROCO:6612
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ICARES Medicus Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of NT$1,438 Mil mean?
ICARES Medicus (ROCO:6612) has a Total Long-Term Assets of NT$1,438 Mil as of Jun. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on ICARES Medicus and its competitors.
Is ICARES Medicus' Total Long-Term Assets too high?
ICARES Medicus' current Total Long-Term Assets is NT$1,438 Mil. Overall, ICARES Medicus has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ICARES Medicus' Total Long-Term Assets compare to ISRG and BDX?
ICARES Medicus' Total Long-Term Assets of NT$1,438 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Medical Devices & Instruments company?
A good Total Long-Term Assets depends on the Medical Devices & Instruments industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on ICARES Medicus and its competitors. ICARES Medicus's current Total Long-Term Assets is NT$1,438 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICARES Medicus stock overvalued right now?
Based on GuruFocus' analysis, ICARES Medicus (ROCO:6612) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$152.19, compared to a current price of NT$70.80 — trading 53.5% below its estimated fair value. The current Total Long-Term Assets is NT$1,438 Mil. ICARES Medicus' overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For ICARES Medicus (ROCO:6612), the current Total Long-Term Assets is NT$1,438 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ICARES Medicus (ROCO:6612) Overvalued in 2026?

Based on GuruFocus' analysis, ICARES Medicus stock appears to be undervalued. The current stock price of NT$70.80 is trading 53.5% below its estimated GF Value™ of NT$152.19. GuruFocus considers ICARES Medicus to be Significantly Undervalued.

Key valuation signals for ROCO:6612:

  • Total Long-Term Assets: NT$1,438 Mil
  • GF Value™: NT$152.19 vs. price of NT$70.80 (53.5% below fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ICARES Medicus Business Description

Address Section 2, Shengyi Road, No. 16, 4th Floor, Hsinchu County, Zhubei, TWN, 30261
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices. In addition, it also designs, develops, manufactures, and sells intraocular lenses and nanomedical devices. The company's operating segments are Europe and America, which derive maximum revenue, China, and R.O.C. Geographically, it generates maximum revenue from the United States, followed by Taiwan, Spain, England, Japan, China, Germany, and other countries.
85GF Score

Get the complete analysis for ROCO:6612

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$70.80
Price
NT$152.19
GF Value